Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 02'nd Apr 2021
EMERYVILLE, Calif., April 2, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 142,000 sha
Dynavax Stock Is Trading Higher As Adjuvanted COVID-19 Vaccine Trial Moves Forward
06:46am, Wednesday, 24'th Mar 2021
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have dosed the first participants in the SPECTRA trial of Clover's COVID-19 vaccine candidate adjuvanted with Dynava
Dynavax Technologies: A Surprising COVID-19 Play
06:49pm, Monday, 01'st Mar 2021
Dynavax Technologies: A Surprising COVID-19 Play
Why Dynavax Stock Is Crushing It Today
11:00am, Friday, 26'th Feb 2021
The biotech's better-than-expected Q4 update pointed to even better days ahead.
DVAX Stock Price Increases Over 9% Pre-Market: Why It Happened
08:19am, Friday, 26'th Feb 2021
The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by over 9% pre-market. This is why it happened.
Dynavax's Q4 Results Show It's Not Just About Heplisav-B Anymore
06:00am, Friday, 26'th Feb 2021
The company's collaborations and CpG 1018 vaccine adjuvant are playing an increasingly important role.
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2020 Results - Earnings Call Transcript
07:19pm, Thursday, 25'th Feb 2021
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q4 2020 Results - Earnings Call Transcript
Dynavax Announces Fourth Quarter and Full Year 2020 Financial Results
04:02pm, Thursday, 25'th Feb 2021
EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today reported
Has Dynavax Technologies (DVAX) Outpaced Other Medical Stocks This Year?
12:09pm, Wednesday, 24'th Feb 2021
Is (DVAX) Outperforming Other Medical Stocks This Year?
Why Dynavax Stock Jumped Today
03:33pm, Friday, 19'th Feb 2021
The company's hepatitis B virus vaccine won European Union approval.
Dynavax Announces European Commission Marketing Authorization for HEPLISAV B®, a 2 Dose Adult Hepatitis B Adjuvanted Vaccine
12:20pm, Friday, 19'th Feb 2021
EMERYVILLE, Calif., Feb. 19, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced
Dynavax Technologies (DVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
01:42pm, Thursday, 18'th Feb 2021
Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: Dynavax (DVAX)
07:36am, Tuesday, 16'th Feb 2021
Dynavax Technologies (DVAX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Week In Review: Junshi Signs $1.1 Billion Deal For U.S.-Canada Rights To PD-1
03:38pm, Sunday, 07'th Feb 2021
Week In Review: Junshi Signs $1.1 Billion Deal For U.S.-Canada Rights To PD-1
DVAX Stock Price Increased 62.76%: Why It Happened
08:49pm, Monday, 01'st Feb 2021
The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by 62.76% today. This is why it happened.
